|
⚲
|
| Keyboard |
| Stancic Ana
✚
|
|
|---|---|
| CIK # | 0001320271 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001320271] | |
| 4 | [0001320271] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Stancic Ana | |
| Immune Pharmaceuticals Inc | |
| K-V Pharmaceutical Co | |
| Enzon Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Immune Pharmaceuticals Inc IMNP
Stock Option · derivative
|
2015-01-08 | Grant | 50,000 | $0.00 | |
|
Immune Pharmaceuticals Inc IMNP
Common Stock
|
2014-11-26 | Buy | 8,000 | $2.50 | 20,000 |
|
Immune Pharmaceuticals Inc IMNP
Warrant · derivative
|
2014-11-26 | Buy | 2,000 | ||
|
Immune Pharmaceuticals Inc IMNP
Stock Option (right to buy) · derivative
|
2013-10-10 | Grant | 50,000 | ||
|
Immune Pharmaceuticals Inc IMNP
Stock Option (right to buy) · derivative
|
2013-10-10 | Grant | 50,000 | ||
|
K-V Pharmaceutical Co KVA/KVB
Option to Purchase · derivative
|
2013-09-16 | Other | 10,000 | $0.00 | |
|
K-V Pharmaceutical Co KVA/KVB
Option to Purchase · derivative
|
2013-09-16 | Other | 20,000 | $0.00 | |
|
K-V Pharmaceutical Co KVA/KVB
Option to Purchase · derivative
|
2013-09-16 | Other | 20,000 | $0.00 | |
|
K-V Pharmaceutical Co KVA/KVB
Option to Purchase · derivative
|
2013-09-16 | Other | 7,500 | $0.00 | |
|
K-V Pharmaceutical Co KVA
Option to Purchase · derivative
|
2012-05-14 | Grant | 20,000 | $0.00 | |
|
Enzon Pharmaceuticals Inc ENZN
Common Stock
|
2012-01-17 | Grant | 45,000 | $0.00 | |
|
Enzon Pharmaceuticals Inc ENZN
Common Stock
|
2012-01-17 | Disposed to issuer | 45,000 | $0.00 |